107 related articles for article (PubMed ID: 9230491)
1. Construction of scales for the Center for Marital and Sexual Health (CMASH) Sexual Functioning Questionnaire.
Glick HA; McCarron TJ; Althof SE; Corty EW; Willke RJ
J Sex Marital Ther; 1997; 23(2):103-17. PubMed ID: 9230491
[TBL] [Abstract][Full Text] [Related]
2. The reliability and validity of a sexual functioning questionnaire.
Corty EW; Althof SE; Kurit DM
J Sex Marital Ther; 1996; 22(1):27-34. PubMed ID: 8699494
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction.
Gheorghiu S; Godschalk M; Gentili A; Mulligan T
J Urol; 1996 Jul; 156(1):80-1. PubMed ID: 8648844
[TBL] [Abstract][Full Text] [Related]
4. Quality of life effects of alprostadil therapy for erectile dysfunction.
Willke RJ; Glick HA; McCarron TJ; Erder MH; Althof SE; Linet OI
J Urol; 1997 Jun; 157(6):2124-8. PubMed ID: 9146597
[TBL] [Abstract][Full Text] [Related]
5. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
Chen RN; Lakin MM; Montague DK; Ausmundson S
J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
[TBL] [Abstract][Full Text] [Related]
6. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B
Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study.
Latini DM; Penson DF; Lubeck DP; Wallace KL; Henning JM; Lue TF
J Urol; 2003 Apr; 169(4):1437-42. PubMed ID: 12629379
[TBL] [Abstract][Full Text] [Related]
8. Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation.
Rosen RC; Catania J; Pollack L; Althof S; O'Leary M; Seftel AD
Urology; 2004 Oct; 64(4):777-82. PubMed ID: 15491719
[TBL] [Abstract][Full Text] [Related]
9. [Erectile response to intracavernous injection of linsidomine in 38 impotent patients. Comparison with prostaglandin E1].
Lemaire A; Buvat J
Prog Urol; 1998 Jun; 8(3):388-91. PubMed ID: 9689672
[TBL] [Abstract][Full Text] [Related]
10. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
[TBL] [Abstract][Full Text] [Related]
11. [Prostaglandin E1 in the diagnosis and therapy of erectile disorders].
Loran OB; Segal AS; Shcheplev PA
Urol Nefrol (Mosk); 1995; (4):35-8. PubMed ID: 7571200
[TBL] [Abstract][Full Text] [Related]
12. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness and minimum important differences for the erection quality scale.
Rosen RC; Wincze J; Mollen MD; Gondek K; McLeod LD; Fisher WA
J Urol; 2007 Nov; 178(5):2076-81. PubMed ID: 17869291
[TBL] [Abstract][Full Text] [Related]
14. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
Vardi Y; Lidgi S; Moskovitz B; Levin RD
Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder.
Clayton AH; Segraves RT; Leiblum S; Basson R; Pyke R; Cotton D; Lewis-D'Agostino D; Evans KR; Sills TL; Wunderlich GR
J Sex Marital Ther; 2006; 32(2):115-35. PubMed ID: 16418104
[TBL] [Abstract][Full Text] [Related]
16. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14).
Keller A; McGarvey EL; Clayton AH
J Sex Marital Ther; 2006; 32(1):43-52. PubMed ID: 16234225
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic and diagnostic potentials of the intra-corpora cavernosa use of alprostadil, Edex, in patients with erectile dysfunction].
Mzo EB; Dmitriev DG
Ter Arkh; 1995; 67(10):45-8. PubMed ID: 8779105
[TBL] [Abstract][Full Text] [Related]
18. Office treatment: intracavernous injections of prostaglandin E1 (PG E1) and improvement of spontaneous erections.
Beretta G; Marzotto M; Zanollo A; Re B
Acta Eur Fertil; 1991; 22(4):221-3. PubMed ID: 1844326
[TBL] [Abstract][Full Text] [Related]
19. The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners.
DiBenedetti DB; Gondek K; Sagnier PP; Kubin M; Marquis P; Keininger D; Fugl-Meyer AR
Eur Urol; 2005 Sep; 48(3):503-11. PubMed ID: 15964130
[TBL] [Abstract][Full Text] [Related]
20. A prospective long-term follow-up study of patients evaluated for erectile dysfunction: outcome and associated factors.
Speckens AE; Kattemölle MR; Hengeveld MW; Lycklama A Nijeholt AB; Van Hemert AM; Hawton KE
Int J Impot Res; 1995 Jun; 7(2):101-10. PubMed ID: 7496438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
